Novel anti-inflammatory functions for endothelial and myeloid cyclooxygenase-2 in a new mouse model of Crohn's disease (Q43124597)

14 November 2017

Novel anti-inflammatory functions for endothelial and myeloid cyclooxygenase-2 in a new mouse model of Crohn's disease (English)

1 reference

14 November 2017

0 references

Junji Watanabe

1

1 reference

14 November 2017

James A Lin

2

1 reference

14 November 2017

Ajay J Narasimha

3

1 reference

14 November 2017

Ani Shahbazian

4

1 reference

14 November 2017

Tomo-O Ishikawa

5

1 reference

14 November 2017

Martin G Martin

6

1 reference

14 November 2017

Harvey R Herschman

7

1 reference

14 November 2017

Srinivasa T Reddy

8

1 reference

14 November 2017

18 March 2010

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

14 November 2017

1 reference

14 November 2017

298

1 reference

14 November 2017

6

1 reference

14 November 2017

G842-50

1 reference

VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells.

14 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Regulation by prostaglandin E2 of interleukin release by T lymphocytes in mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Defective IL-10 production in severe phenotypes of Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Hydrophobic characterization of intracellular lipids in situ by Nile Red red/yellow emission ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Nile red: a selective fluorescent stain for intracellular lipid droplets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Development and validation of a novel IL-10 deficient cell transfer model for colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Conditional knockout mouse for tissue-specific disruption of the cyclooxygenase-2 (Cox-2) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Atherogenic diet causes lethal ileo-ceco-colitis in cyclooxygenase-2 deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

The problem of passenger genes in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Interferon-gamma (IFN-gamma) and prostaglandin E2 (PGE2) regulate differently IL-12 production in human intestinal lamina propria mononuclear cells (LPMC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Risk of cardiovascular events associated with selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Absence of myeloid COX-2 attenuates acute inflammation but does not influence development of atherosclerosis in apolipoprotein E null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Inducible gene knockouts in the small intestinal and colonic epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Phagocytotic activation of muscularis resident macrophages inhibits smooth muscle contraction in rat ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear str

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

New insights into the mode of action of anti-inflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

An overview of the biological significance of endogenous gases: new roles for old molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00468.2009

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00468.2009

1 reference

14 November 2017

1 reference